Chronic Obstructive Pulmonary Disease (COPD)

GOLD Guidelines

• Evidence-based strategy document for COPD diagnosis, management and prevention 

CTS Guidelines

• Canadian Journal of Respiratory 2023 Guidelines

1. What is the defining characteristic of Chronic Obstructive Pulmonary Disease (COPD)?

a) Complete reversibility of airway limitation

b) Progressive, partially reversible airway limitation

c) Inflammation of lung tissue only during infections

d) Temporary shortness of breath without activity limitation

2. What diagnostic measure confirms COPD?

a) X-ray findings

b) Physical examination of lung sounds

c) Spirometry with FEV1/FVC < 0.7 post-bronchodilation

d) Family history alone

3. Which GOLD Grade corresponds to "Moderate" airflow obstruction in COPD?

a) GOLD 1

b) GOLD 2

c) GOLD 3

d) GOLD 4

4. Which of the following is NOT a goal of COPD therapy?

a) Prevent disease progression

b) Increase breathlessness to monitor symptoms

c) Improve exercise tolerance

d) Reduce frequency and severity of exacerbations

5. Which factor is considered a primary risk factor for developing COPD?

a) Genetic mutations

b) Indoor/outdoor pollution

c) Low physical activity

d) Excessive alcohol consumption

6. What is the primary recommendation for non-pharmacologic COPD management?

a) Lung surgery

b) Annual influenza and pneumococcal vaccines

c) Immediate use of antibiotics

d) Use of oral steroids year-round

7. When managing an acute exacerbation of COPD (AECOPD), what is the initial pharmacologic treatment?

a) Antibiotics alone

b) Scheduled salbutamol +/- ipratropium

c) Intravenous steroids

d) Surgery

8. Which antibiotic is recommended for high-risk COPD patients during an AECOPD with a change in sputum purulence and increased sputum volume or dyspnea?

a) Doxycycline

b) Azithromycin

c) Amoxiclav

d) Cefprozil